|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 2018 | James Thompson to Assume the Position of President and Chief Executive Officer of Callitas Health Inc | CI |
| 2018 | Callitas Health Inc. Announces Management Changes | CI |
On February 13, 2015, M Pharmaceutical Inc. closed the transaction. The company amended the terms of the transaction. The company issued additional 10,250,000 units for gross proceeds of CAD 205,000 in its final tranche, bringing total gross proceeds raised to CAD 1,080,000.
The securities issued in final tranche will be subject to trading restrictions until June 14, 2015.
| 1st Jan change | Capi. | |
|---|---|---|
| +9,900.00% | 4.53K | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
CALLITAS HEALTH INC. 
